Address :55 CORPORATE DR BRIDGEWATER, NJ, 08807-1265 UNITED STATES | |||
Status : A | Type : A | Woman Owned : N | Business Type : N |
Business Size : E | Primary Business : J | CAO Code : S3101A | ADP Code : HQ0337 |
Part No | Item Name | Manufacturer | NSN | QTY | RFQ |
---|---|---|---|---|---|
NDC00088-1777-47 | diltiazem extended | Sanofi Aventis U S Llc | 6505-01-309-2741 | Avl | RFQ |
NDC00068-0019-01 | desipramine hydrochloride tablet | Sanofi Aventis U S Llc | 6505-01-153-4416 | Avl | RFQ |
NDC52604-1575-01 | niacin extended rel | Sanofi Aventis U S Llc | 6505-01-169-7487 | Avl | RFQ |
NDC00088-1771-47 | diltiazem tablets u | Sanofi Aventis U S Llc | 6505-01-145-8825 | Avl | RFQ |
NDC00088-1555-90 | papaverine hydrochloride extende | Sanofi Aventis U S Llc | 6505-01-156-2064 | Avl | RFQ |
NDC00088-0777-47 | thyroid tablets usp | Sanofi Aventis U S Llc | 6505-01-082-1218 | Avl | RFQ |
NDC00088-1800-13 | nitroglycerin injection usp | Sanofi Aventis U S Llc | 6505-01-127-5164 | Avl | RFQ |
NDC00088-1550-41 | nitroglycerin extended release c | Sanofi Aventis U S Llc | 6505-01-156-1736 | Avl | RFQ |
NDC00088-1790-33 | diltiazem hydrochlo | Sanofi Aventis U S Llc | 6505-01-353-9827 | Avl | RFQ |
NDC00088-1800-32 | nitroglycerin injection usp | Sanofi Aventis U S Llc | 6505-01-470-3206 | Avl | RFQ |
26-15-04 | fecal specimen collection and preparatio | Sanofi Aventis U S Llc | 6550-01-153-3989 | Avl | RFQ |
NDC00066-0494-25 | clindamycin benzoyl peroxide gel | Sanofi Aventis U S Llc | 6505-01-600-7402 | Avl | RFQ |
NDC00088-1109-47 | fexofenadine hydrochloride table | Sanofi Aventis U S Llc | 6505-01-505-7721 | Avl | RFQ |
NDC00088-1796-49 | diltiazem extended release capsules usp | Sanofi Aventis U S Llc | 6505-01-353-9844 | Avl | RFQ |
NDC00088-1088-41 | glycyrrhiza mixture compound loz | Sanofi Aventis U S Llc | 6505-01-143-6831 | Avl | RFQ |
NDC00088-1712-47 | sucralfate tablets | Sanofi Aventis U S Llc | 6505-01-123-0984 | Avl | RFQ |
26-15-06 | polyvinyl alcohol fixative | Sanofi Aventis U S Llc | 6550-01-234-1529 | Avl | RFQ |
NDC00088-1779-47 | diltiazem extended release capsu | Sanofi Aventis U S Llc | 6505-01-286-5641 | Avl | RFQ |
NDC00075-1506-16 | triamcinolone aceto | Sanofi Aventis U S Llc | 6505-01-515-2457 | Avl | RFQ |
NDC00088-1553-41 | nitroglycerin extended release c | Sanofi Aventis U S Llc | 6505-01-148-2428 | Avl | RFQ |
NDC00088-1050-58 | sulfadiazinesilvercream | Sanofi Aventis U S Llc | 6505-01-178-3944 | Avl | RFQ |
NDC00088-0052-61 | nicotine transdermal | Sanofi Aventis U S Llc | 6505-01-353-7717 | Avl | RFQ |
NDC00088-1771-90 | diltiazem tablets usp | Sanofi Aventis U S Llc | 6505-01-362-7385 | Avl | RFQ |
NDC00088-1551-47 | nitroglycerin extended release c | Sanofi Aventis U S Llc | 6505-00-283-3200 | Avl | RFQ |
8U34526 | kingpin fifth wheel | Sanofi Aventis U S Llc | 2510-01-214-4516 | Avl | RFQ |
6640012174389 | viral specimen collection and transportation syste | Sanofi Aventis U S Llc | 6550-01-326-4462 | Avl | RFQ |
FLU 2005-2006 | influenza virus vaccine usp | Sanofi Aventis U S Llc | 6505-01-528-3870 | Avl | RFQ |
NDC00088-1772-47 | diltiazem tablets u | Sanofi Aventis U S Llc | 6505-01-146-4174 | Avl | RFQ |
NDC00088-1798-30 | diltiazem extended release capsu | Sanofi Aventis U S Llc | 6505-01-354-3160 | Avl | RFQ |
00088-1771-49 | diltiazem tablets usp | Sanofi Aventis U S Llc | 6505-01-167-5382 | Avl | RFQ |
26-15-08 | fecal specimen collection and preparation kit | Sanofi Aventis U S Llc | 6550-01-174-2365 | Avl | RFQ |
NDC00024-5421-31 | zolpidem tartrate t | Sanofi Aventis U S Llc | 6505-01-435-4310 | Avl | RFQ |
NDC00888-1102-55 | fexofenadine hydrochloride capsu | Sanofi Aventis U S Llc | 6505-01-443-2358 | Avl | RFQ |
NDC00088-1650-58 | calcium carbonate and vitamin d | Sanofi Aventis U S Llc | 6505-00-550-2893 | Avl | RFQ |
NDC00088-1800-31 | nitroglycerininjection usp | Sanofi Aventis U S Llc | 6505-01-132-7836 | Avl | RFQ |
NDC00088-1553-41 | nitroglycerin extended release c | Sanofi Aventis U S Llc | 6505-01-086-8787 | Avl | RFQ |
NDC00088-1797-49 | diltiazem extended release capsu | Sanofi Aventis U S Llc | 6505-01-353-9843 | Avl | RFQ |
NDC00088-1800-33 | nitroglycerin injection usp | Sanofi Aventis U S Llc | 6505-01-281-6225 | Avl | RFQ |
26-15-14 | viral specimen collection and transportation syste | Sanofi Aventis U S Llc | 6550-01-326-4462 | Avl | RFQ |
26-40-01 | test kit clostridium difficile cytotoxin detection | Sanofi Aventis U S Llc | 6550-01-267-2472 | Avl | RFQ |
26-30-04 | testkit streptococcigroupade | Sanofi Aventis U S Llc | 6550-01-234-5376 | Avl | RFQ |
NDC00088-1375-58 | oxybutynin chloride tablets usp | Sanofi Aventis U S Llc | 6505-01-037-4427 | Avl | RFQ |
NDC00088-1555-47 | papaverine hydrochloride tablets | Sanofi Aventis U S Llc | 6505-01-153-3516 | Avl | RFQ |
26-15-04 | fecal specimen collection and preparation kit | Sanofi Aventis U S Llc | 6550-01-075-4011 | Avl | RFQ |
NDC00088-1102-49 | fexofenadine hydrochloride capsu | Sanofi Aventis U S Llc | 6505-01-443-2357 | Avl | RFQ |
NDC00088-1772-55 | diltiazem tablets usp | Sanofi Aventis U S Llc | 6505-01-322-6501 | Avl | RFQ |
NDC00088-1800-32 | nitroglycerininjection usp | Sanofi Aventis U S Llc | 6505-01-200-7183 | Avl | RFQ |
26-11-90 | ferric chloride sol | Sanofi Aventis U S Llc | 6550-01-227-3601 | Avl | RFQ |
NDC00088-1772-49 | diltiazem tablets usp | Sanofi Aventis U S Llc | 6505-01-167-5383 | Avl | RFQ |
NDC00088-1551-41 | nitroglycerin extended release c | Sanofi Aventis U S Llc | 6505-01-006-7518 | Avl | RFQ |
All Orders are Fulfilled in the U.S.A.
All shipments must comply with U.S.A export laws.
No exceptions.
The only independent distributor
with a NO CHINA SOURCING Pledge
“We Proudly Support Intrepid Fallen Heroes Fund that serves United States Military Personal experiencing the Invisible Wounds of War : Traumatic Brain Injury (TBI) and Post Traumatic Stress (PTS). Please visit website (www.fallenheroesfund.org) and help in their valiant effort”.
Don’t forget That We offer Same-Day Shipping and 24/7 Service for Our Customers.
Request for Quote